2007 – Opening of the Clinical Headquarters by [email protected] | Dec 13, 2017Accell is established as a clinical CRO providing Phase I – IV clinical study management services. The company serves as a reliable partner in completing clinical studies on time, and the first three Phase II oncology studies are initiated.
Recent Comments